Erasca, Inc. (ERAS)
3.385
+0.12
(+3.83%)
USD |
NASDAQ |
Dec 11, 13:36
Erasca Market Cap: 960.36M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ALX Oncology Holdings, Inc. | 82.95M |
| Prelude Therapeutics, Inc. | 101.84M |
| Atea Pharmaceuticals, Inc. | 249.62M |
| Immuneering Corp. | 417.12M |
| ProKidney Corp. | 317.06M |
Market Cap Related Metrics
| Price to Book Value | 2.761 |
| Price | 3.385 |
| Earnings Yield | -13.32% |